Track medtech innovations from your desktop, subscribe to Innovation Hub.

Learn More

Market Reports

Reports available individually or as part of a full Medtech Pro subscription.

December Emerging Medical Technologies Report

58 Pages | 60 Exhibits |
This report includes details on 60 emerging medical technology companies that have been identified by LSI's in-house research team in December 2013. Additionally, read LSI's "Innovator of the Month" Interview with: - Mir Imran, Founder & Chairman, InCube Labs All companies include technology, market(s), key executive, and contact information. Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Biomaterials Companies- Biotech...

March Emerging Medical Technologies Report

17 Pages | 30 Exhibits |
This report includes details on 30 emerging medical technology companies that have been identified by LSI\'s in-house research team in March 2013. All companies include technology, market(s), key executive, and contact information. Coverage includes innovations in a broad spectrum of medical technology areas including: - Aesthetics/Dermatology Companies - Biomaterials Companies - Biotechnology/Cell Therapy Companies - Cardiovascular Companies - Dental Companies - Diagnostics Companie...

Global Opportunities in Obesity Management Technologies

238 Pages | 75 Exhibits | Forecasts Through 2018
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.

January Emerging Medical Technologies Report

101 Pages | 47 Exhibits |
This report includes details on 47 emerging medical technology companies that have been identified by LSI\'s in-house research team in January 2012. All companies include technology, market(s), key executive, and contact information. Two- to three-page executive summaries are provided on most of the companies. Executive summaries typically include: • Company Contact Information • Company Overview (structure, size, year founded, etc.) • Competitive Landscape • Technological Advantag...

U.S. Markets for Small Joint Implants & Hardware for The Extremities

142 Pages | 62 Exhibits | Forecasts Through 2017
Despite continued economic challenges, the U.S. market for small joint implants and extremities\' hardware will experience healthy growth through 2017. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare. In the U.S., growth will be influenced by the continued adoption...

OUS Markets for Small Joint Implants & Hardware for The Extremities

194 Pages | 105 Exhibits | Forecasts Through 2017
Despite continued economic challenges, the OUS market for small joint implants and extremities\' hardware will experience healthy growth through 2017. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare. In the U.S., growth will be influenced by the continued adoption...

February Emerging Medical Technologies Report

95 Pages | 43 Exhibits |
This report includes details on 43 emerging medical technology companies that have been identified by LSI\'s in-house research team in February 2012. All companies include technology, market(s), key executive, and contact information. Two- to three-page executive summaries are provided on most of the companies. Executive summaries typically include: • Company Contact Information • Company Overview (structure, size, year founded, etc.) • Competitive Landscape • Technological Advanta...

Global Markets for Large Joint Replacement Technologies

154 Pages | 78 Exhibits | Forecasts Through 2017
Economic constraints and unemployment have had adverse effects on sales of large joint replacement technologies in developed markets. However, the underlying factors driving the performance of hip and knee replacement surgeries - such as rising disease prevalence and aging populations - will continue to generate opportunities for device suppliers. In particular, the growing adoption of these products in emerging markets should help to offset weaker conditions in the U.S. and Western Europe....

U.S. Markets for Large Joint Replacement Technologies

94 Pages | 34 Exhibits | Forecasts Through 2017
The U.S. market has seen strong economic headwinds in recent years, limiting sales of hip and knee replacement technologies. Other factors, such as the shift away from metal-on-metal total hip arthroplasty devices and the introduction of patient-matched knee replacement products, have had significant effects on market growth and product preferences. While clinical preferences and the advanced features of recent product introductions will influence trends in the market, the main factors aff...

OUS Markets for Large Joint Replacement Technologies

118 Pages | 52 Exhibits | Forecasts Through 2017
Opportunities for suppliers of hip and knee replacement technologies outside of the U.S. vary by country. International regions include mature markets such as Western Europe and Japan as well as the emerging economies of Brazil, China, and India. While economic conditions have had negative effects on the European market, the rising prevalence of osteoarthritis, obesity, and an aging population will continue to generate opportunities for suppliers. The market will continue to be influenced by...

March Emerging Medical Technologies Report

81 Pages | 61 Exhibits |
This report includes details on 61 emerging medical technology companies that have been identified by LSI\'s in-house research team in March 2012. All companies include technology, market(s), key executive, and contact information. Two- to three-page executive summaries are provided on most of the companies. Executive summaries typically include: • Company Contact Information • Company Overview (structure, size, year founded, etc.) • Competitive Landscape • Technological Advantage...

U.S. Long-Term Acute Care Markets

140 Pages | 58 Exhibits | Forecasts Through 2017
Faced with escalating costs, acute hospitals require alternative care locations to accommodate the needs of extended-stay patients, who account for a substantial proportion of healthcare expenditures. Long-term acute care hospitals (LTACHs) are designed to accommodate the complex needs of these patients. These hospitals offer a range of services that includes mechanical ventilation and respiratory therapy, wound care, dialysis, and cardiopulmonary monitoring. LTACHs offer an attractive, niche...

September Emerging Medical Technologies Report

15 Pages | 30 Exhibits |
This report includes details on 30 emerging medical technology companies that have been identified by LSI\'s in-house research team in September 2012. All companies include technology, market(s), key executive, and contact information. Coverage includes innovations in a broad spectrum of medical technology areas including: - Aesthetics/Dermatology Companies - Biomaterials Companies - Biotechnology/Cell Therapy Companies - Cardiovascular Companies - Dental Companies - Diagnostics Comp...

Global Markets for Aesthetic Products

142 Pages | 71 Exhibits | Forecasts Through 2017
The global market for the aesthetic devices analyzed in this report was valued at nearly $4.3 billion in 2011. The market has fluctuated in recent years and saw declines in 2009. The year 2011, however, was marked by higher sales volumes than in historical years, largely due to the growing popularity of aesthetic procedures as a means to improve appearance or restore a youthful look as well as the growing availability of non-surgical treatments. The emergence of markets in Asia and South America...

Global Markets for Neurosurgical Products

204 Pages | 104 Exhibits | Forecasts Through 2018
The global market for neurosurgical products will exceed $2.7B in sales in 2013. The market is characterized by the existence of different tiers of development among mature and emerging markets. Growth in the developed markets is being driven by trends in the frequency of key conditions, such as hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors, while economic constraints will continue to play an important role in product pricing and the adoptio...